South Africa in the news: Covid live news: UK reports 36,722 new cases as weekly deaths in Scotland highest since February: Latest UK-wide case figures come as Scotland sees rise in hospitalisations. 18:24 The Pan American Health Organization (PAHO) is in advanced talks with vaccine manufacturers to purchase …: “South Africa” – BingNews Boeing …
COVID vaccine weekly: do British teenagers really need vaccinating more than adults overseas?: Monkey Business Images/Shutterstock Close to 40 million people in the UK have had two COVID vaccine doses. This gives Britain one of the highest rates of coverage in the world, with nearly 60% of the population fully vaccinated. And with vaccines soon …
COVID vaccine weekly: reopening will test the strength of England’s immunity: England has now lifted nearly all of its coronavirus restrictions. Cases are high and rising, but the country’s vaccine coverage is among the best the world, meaning that the power of vaccines to control the virus will now be firmly put to the test. …
COVID vaccine weekly: more vaccinated than unvaccinated Britons are now dying from the coronavirus: Studio Romantic/Shutterstock Coronavirus vaccines lessen the chance of you getting COVID-19 and massively reduce the risk of developing serious illness and being hospitalised. Yet at the same time, most COVID-19 deaths in England are now currently among the vaccinated. Is this …
COVID vaccine weekly: England to lift remaining restrictions as planned: cktravels.com/Shutterstock England’s final COVID-19 restrictions will lift on July 19, despite cases rising sharply in recent weeks and hospitalisations and deaths creeping up too. With the country facing another wave of infections, is now the right time to be fully opening up? It’s a difficult …
COVID vaccine weekly: delta variant exposes the flaws of stop-start vaccination programmes: For many countries, vaccine programmes have been one of the great triumphs of the pandemic. But in South Africa, it’s a very different story. To date, fewer than 5% of South Africans have been vaccinated, and the country is now in the grips …
COVID vaccine weekly: G7 donations unlikely to bring pandemic to an end by 2022: The dust from the G7 summit has settled and big statements have been made: the leaders of the world’s richest democracies have set the target of ending the pandemic by the close of 2022. The question is whether their actions match …
COVID vaccine weekly: sharing doses tops the G7 agenda: Forging an agreement to get vaccines fully distributed across the world by the end of 2022 will be a top priority at the forthcoming G7 summit, with the UK prime minister Boris Johnson due to formally set out this target when the heads of state meet …
COVID vaccine weekly: both vaccine doses needed for good protection against B16172 variant: It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live …
COVID vaccine weekly: Britain expands rollout to avoid variant delaying end of lockdown: Pubs, restaurants and cafes in England, Scotland and Wales are now able to serve customers indoors. Andy Rain/EPA-EFE England, Scotland and Wales eased their lockdown restrictions this week, despite concerns about the rise in new cases caused by the B16172 variant. If …
COVID vaccine weekly: local lockdowns and vaccination surges could be used to contain B16172 variant: May 17 is probably circled and underlined in many British people’s diaries. It marks a key point in the UK’s exit from lockdown: from this date, six people or two households can mix indoors, indoor drinking and dining can resume, …
COVID vaccine weekly: support builds for patent waiver as shortages threaten to bite: Allison Bailey/Alamy The US has this week backed a proposal to allow countries to manufacture COVID-19 vaccine doses without needing the agreement of the vaccines’ rights holders. This would be enabled by temporarily waiving intellectual property (IP) protection on all COVID-19 medical …
COVID vaccine weekly: India’s crisis deepens, but vaccine sharing is yet to materialise: India’s deadly second wave is continuing to worsen, with daily new cases consistently exceeding 300,000 and deaths now having surpassed 3,000 a day. Hospitals are running out of intensive care beds and many are critically short of oxygen for treating patients. Alarmingly, …
COVID vaccine weekly: UK closes its borders to India to safeguard effects of vaccination: This week the UK passed the milestone of having given 10 million people a second COVID-19 vaccine dose. This means that over 20% of UK adults are now fully vaccinated against the coronavirus. The effects are beginning to show. COVID-19 cases, …
South Africa in the news: 5.2 million covid cases globally set weekly record: More people were diagnosed with covid-19 during the past seven days than any other week since the start of the pandemic — topping 5.2 million globally — with the worst outbreaks accelerating in many …: “South Africa” – BingNews Cape Town wildfire: …
COVID vaccine weekly: safety concerns and reactions in the west dent confidence worldwide: COVID-19 vaccination has hit arguably its biggest hurdle so far. The rollout of two vaccines – AstraZeneca’s and Johnson & Johnson’s – has been paused, restricted or completely stopped in a number of countries as regulators and governments respond to signs that …
COVID vaccine weekly: encouraging results for children and pregnant women: After being safely administered to millions of adults around the world, new data shows that the Pfizer/BioNTech vaccine is effective in teenagers as well. A US trial of more than 2,000 12-15 year olds found that the vaccine had an efficacy rate of 100% and …
COVID vaccine weekly: AstraZeneca’s supplies, efficacy and safety under the microscope again: It’s Groundhog Day for the Oxford/AstraZeneca vaccine. Disputes over supplies and questions about its efficacy have dominated the week, just as they have at various points over the past few months. The EU is considering restricting exports of doses it has manufactured that …